Construction and in vivo efficacy of a replication-deficient recombinant adenovirus encoding murine growth hormone

Endocrinology. 1999 Jan;140(1):260-5. doi: 10.1210/endo.140.1.6400.

Abstract

We have constructed a recombinant, replication-deficient, first-generation adenovirus-encoding mouse GH (mGH), AdCMVmGH. This virus directed mGH production from an epithelial cell line in vitro in a dose-dependent manner. When injected into the quadriceps muscle or submandibular ducts of mGH-deficient Snell dwarf mice, AdCMVmGH resulted in the production of significantly elevated serum mGH levels. Furthermore, after i.m. injection, dwarf mice increased in weight by 8% over 4 days and close to 100% by 30 days. When AdCMVmGH was administered to 3- to 4-week-old rats by i.v. injection to assess general metabolic responses, serum mGH, insulin-like growth factor 1, triglycerides and cholesterol levels were significantly elevated. AdCMVmGH should be a valuable experimental tool for the controlled, directed expression of mGH in preclinical mouse model studies.

MeSH terms

  • Adenoviridae / genetics*
  • Adenoviridae / physiology
  • Animals
  • Body Weight / drug effects
  • Cell Line
  • Chromosomes
  • DNA-Binding Proteins / genetics
  • Gene Transfer Techniques
  • Growth Hormone / genetics*
  • Growth Hormone / pharmacology*
  • Injections, Intramuscular
  • Mice
  • Muscle, Skeletal / drug effects
  • Pituitary Hormones, Anterior / biosynthesis
  • Pituitary Hormones, Anterior / genetics
  • Radioimmunoassay
  • Rats
  • Rats, Wistar
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Submandibular Gland / drug effects
  • Transcription Factor Pit-1
  • Transcription Factors / genetics
  • Virus Replication

Substances

  • DNA-Binding Proteins
  • Pit1 protein, mouse
  • Pituitary Hormones, Anterior
  • Pou1f1 protein, rat
  • Recombinant Proteins
  • Transcription Factor Pit-1
  • Transcription Factors
  • Growth Hormone